Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 2001 May;91(5):727–733. doi: 10.2105/ajph.91.5.727

Barriers to universal prenatal HIV testing in 4 US locations in 1997.

R A Royce 1, E B Walter 1, M I Fernandez 1, T E Wilson 1, J R Ickovics 1, R J Simonds 1; Perinatal Guidelines Evaluation Project1
PMCID: PMC1446691  PMID: 11344880

Abstract

OBJECTIVES: We determined rates of prenatal HIV testing and investigated barriers to testing. METHODS: We surveyed 1362 representative parturient women from 7 hospitals in 4 locations of the United States. RESULTS: Overall, 89.9% of women reported being offered HIV testing and 69.6% reported being tested. Proportions of women not offered testing differed by location (range = 5.2%-16.3%), as did proportions not tested (range = 12.2%-54.4%). Among women who perceived that their clinicians had not recommended testing, 41.7% were tested, compared with 92.8% of women who perceived a strong recommendation (P < .05). Private insurance for prenatal care was also associated with not being tested. Women gave multiple reasons for not being tested, most commonly not being at risk, having been tested recently, and the test's not being offered or recommended, cited by 55.3%, 39.1% and 11.1% of women, respectively. CONCLUSIONS: Although most parturient women were offered a prenatal HIV test and got tested, testing proportions did not reach national goals and differed significantly by location and payment status. Concern about testing consequences was not a major barrier. Perception of clinicians' recommendations strongly influenced testing. Changing provider practices will be essential to implementing universal prenatal HIV testing.

Full Text

The Full Text of this article is available as a PDF (93.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbacci M., Repke J. T., Chaisson R. E. Routine prenatal screening for HIV infection. Lancet. 1991 Mar 23;337(8743):709–711. doi: 10.1016/0140-6736(91)90286-x. [DOI] [PubMed] [Google Scholar]
  2. Cartoux M., Msellati P., Meda N., Welffens-Ekra C., Mandelbrot L., Leroy V., Van de Perre P., Dabis F. Attitude of pregnant women towards HIV testing in Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la Transmission Mère Enfant du VIH. Agence Nationale de Recherches sur le SIDA. AIDS. 1998 Dec 3;12(17):2337–2344. doi: 10.1097/00002030-199817000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carusi D., Learman L. A., Posner S. F. Human immunodeficiency virus test refusal in pregnancy: a challenge to voluntary testing. Obstet Gynecol. 1998 Apr;91(4):540–545. doi: 10.1016/s0029-7844(97)00714-x. [DOI] [PubMed] [Google Scholar]
  4. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
  5. Cozen W., Mascola L., Enguidanos R., Bauch S., Giles M., Paxton P., Henneman C., Finn M. Screening for HIV and hepatitis B virus in Los Angeles County prenatal clinics: a demonstration project. J Acquir Immune Defic Syndr. 1993 Jan;6(1):95–98. [PubMed] [Google Scholar]
  6. Dabis F., Msellati P., Meda N., Welffens-Ekra C., You B., Manigart O., Leroy V., Simonon A., Cartoux M., Combe P. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant. Lancet. 1999 Mar 6;353(9155):786–792. doi: 10.1016/s0140-6736(98)11046-2. [DOI] [PubMed] [Google Scholar]
  7. Faden Ruth R., Gielen Andrea C., Kass Nancy, O'Campo Patricia, Anderson Jean, Chaisson Richard, Sheon Amy. Prenatal HIV-antibody testing and the meaning of consent. AIDS Public Policy J. 1994 Fall;9(3):151–159. [PubMed] [Google Scholar]
  8. Guay L. A., Musoke P., Fleming T., Bagenda D., Allen M., Nakabiito C., Sherman J., Bakaki P., Ducar C., Deseyve M. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999 Sep 4;354(9181):795–802. doi: 10.1016/S0140-6736(99)80008-7. [DOI] [PubMed] [Google Scholar]
  9. Healton C., Messeri P., Abramson D., Howard J., Sorin M. D., Bayer R. A balancing act: the tension between case-finding and primary prevention strategies in New York State's voluntary HIV counseling and testing program in women's health care settings. Am J Prev Med. 1996 Jul-Aug;12(4 Suppl):53–60. [PubMed] [Google Scholar]
  10. Jones J. L., Hutto P., Meyer P., Dowda H., Gamble W. B., Jr, Gunn R. A. HIV seroprevalence and reasons for refusing and accepting HIV testing. Sex Transm Dis. 1993 Nov-Dec;20(6):334–337. [PubMed] [Google Scholar]
  11. Leroy V., Newell M. L., Dabis F., Peckham C., Van de Perre P., Bulterys M., Kind C., Simonds R. J., Wiktor S., Msellati P. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet. 1998 Aug 22;352(9128):597–600. doi: 10.1016/s0140-6736(98)01419-6. [DOI] [PubMed] [Google Scholar]
  12. Limata C., Schoen E. J., Cohen D., Black S. B., Quesenberry C. P., Jr Compliance with voluntary prenatal HIV testing in a large health maintenance organization (HMO). J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):126–130. doi: 10.1097/00042560-199706010-00005. [DOI] [PubMed] [Google Scholar]
  13. Lindsay M. K., Adefris W., Peterson H. B., Williams H., Johnson J., Klein L. Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population. Obstet Gynecol. 1991 Oct;78(4):678–680. [PubMed] [Google Scholar]
  14. Lindsay M. K., Feng T. I., Peterson H. B., Slade B. A., Willis S., Klein L. Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstet Gynecol. 1991 Apr;77(4):599–603. [PubMed] [Google Scholar]
  15. Meadows J., Catalan J. Why do antenatal attenders decide to have the HIV antibody test? Int J STD AIDS. 1994 Nov-Dec;5(6):400–404. doi: 10.1177/095646249400500604. [DOI] [PubMed] [Google Scholar]
  16. Myers E. R., Thompson J. W., Simpson K. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. Obstet Gynecol. 1998 Feb;91(2):174–181. doi: 10.1016/s0029-7844(97)00629-7. [DOI] [PubMed] [Google Scholar]
  17. Nduati R., John G., Mbori-Ngacha D., Richardson B., Overbaugh J., Mwatha A., Ndinya-Achola J., Bwayo J., Onyango F. E., Hughes J. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000 Mar 1;283(9):1167–1174. doi: 10.1001/jama.283.9.1167. [DOI] [PubMed] [Google Scholar]
  18. O'Campo P., de Boer M., Faden R., Kass N., Gielen A., Barbacci M. Confirmation of self-report of HIV testing among a cohort of pregnant women. J Clin Epidemiol. 1997 Jan;50(1):57–61. doi: 10.1016/s0895-4356(96)00301-0. [DOI] [PubMed] [Google Scholar]
  19. Phillips K. A., Morrison K. R., Sonnad S. S., Bleecker T. HIV counseling and testing of pregnant women and women of childbearing age by primary care providers: self-reported beliefs and practices. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):174–178. doi: 10.1097/00042560-199702010-00012. [DOI] [PubMed] [Google Scholar]
  20. Riley L. E., Greene M. F. Elective cesarean delivery to reduce the transmission of HIV. N Engl J Med. 1999 Apr 1;340(13):1032–1033. doi: 10.1056/NEJM199904013401308. [DOI] [PubMed] [Google Scholar]
  21. Shaffer N., Chuachoowong R., Mock P. A., Bhadrakom C., Siriwasin W., Young N. L., Chotpitayasunondh T., Chearskul S., Roongpisuthipong A., Chinayon P. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999 Mar 6;353(9155):773–780. doi: 10.1016/s0140-6736(98)10411-7. [DOI] [PubMed] [Google Scholar]
  22. Wade N. A., Birkhead G. S., Warren B. L., Charbonneau T. T., French P. T., Wang L., Baum J. B., Tesoriero J. M., Savicki R. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998 Nov 12;339(20):1409–1414. doi: 10.1056/NEJM199811123392001. [DOI] [PubMed] [Google Scholar]
  23. Walter E. B., Elliott A. J., Regan A. N., Drucker R. P., Clements D. A., Wilfert C. M. Maternal acceptance of voluntary human immunodeficiency virus antibody testing during the newborn period with the Guthrie card. Pediatr Infect Dis J. 1995 May;14(5):376–381. doi: 10.1097/00006454-199505000-00008. [DOI] [PubMed] [Google Scholar]
  24. Wiktor S. Z., Ekpini E., Karon J. M., Nkengasong J., Maurice C., Severin S. T., Roels T. H., Kouassi M. K., Lackritz E. M., Coulibaly I. M. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet. 1999 Mar 6;353(9155):781–785. doi: 10.1016/S0140-6736(98)10412-9. [DOI] [PubMed] [Google Scholar]
  25. Wilson T. E., Minkoff H. Mandatory HIV testing of infants and rates of follow-up care. Am J Public Health. 1999 Oct;89(10):1583–1583. doi: 10.2105/ajph.89.10.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES